PH12019501971A1 - Intradialytic use of sodium thiosulfate - Google Patents
Intradialytic use of sodium thiosulfateInfo
- Publication number
- PH12019501971A1 PH12019501971A1 PH12019501971A PH12019501971A PH12019501971A1 PH 12019501971 A1 PH12019501971 A1 PH 12019501971A1 PH 12019501971 A PH12019501971 A PH 12019501971A PH 12019501971 A PH12019501971 A PH 12019501971A PH 12019501971 A1 PH12019501971 A1 PH 12019501971A1
- Authority
- PH
- Philippines
- Prior art keywords
- sodium thiosulfate
- intradialytic
- methods
- thiosulfate
- subject undergoing
- Prior art date
Links
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 title abstract 2
- 235000019345 sodium thiosulphate Nutrition 0.000 title abstract 2
- 238000001631 haemodialysis Methods 0.000 abstract 2
- 230000000322 hemodialysis Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468871P | 2017-03-08 | 2017-03-08 | |
| PCT/US2018/021069 WO2018165108A1 (en) | 2017-03-08 | 2018-03-06 | Intradialytic use of sodium thiosulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019501971A1 true PH12019501971A1 (en) | 2020-06-15 |
Family
ID=63446695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019501971A PH12019501971A1 (en) | 2017-03-08 | 2019-08-28 | Intradialytic use of sodium thiosulfate |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US10744156B2 (https=) |
| EP (2) | EP4403215A3 (https=) |
| JP (3) | JP7416622B2 (https=) |
| KR (4) | KR20250007674A (https=) |
| AR (1) | AR111236A1 (https=) |
| AU (1) | AU2018231072B2 (https=) |
| CA (1) | CA3055107A1 (https=) |
| ES (1) | ES2992792T3 (https=) |
| IL (4) | IL268883B (https=) |
| NZ (4) | NZ788158A (https=) |
| PH (1) | PH12019501971A1 (https=) |
| TW (2) | TWI869743B (https=) |
| WO (1) | WO2018165108A1 (https=) |
| ZA (2) | ZA202105781B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL268883B (en) | 2017-03-08 | 2022-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| CN112805238A (zh) | 2018-07-03 | 2021-05-14 | 芬内克制药股份有限公司 | 无水硫代硫酸钠和其调配物 |
| US11850313B2 (en) * | 2019-12-20 | 2023-12-26 | The London Health Sciences Centre Research Inc. | Method and compositions for protecting tissue |
| WO2024092228A2 (en) * | 2022-10-28 | 2024-05-02 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Localized delivery of sodium thiosulfate nanoparticles to mitigate arterial calcification |
| CN116573782B (zh) * | 2023-04-03 | 2023-11-03 | 迁安市宏奥工贸有限公司 | 脱硫废液的处理方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0218900B1 (en) | 1985-09-10 | 1992-01-22 | Research Corporation Technologies, Inc. | Osmotic agents for peritoneal dialysis |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
| US6380163B1 (en) | 1992-12-22 | 2002-04-30 | Baxter International Inc. | Peritoneal dialysis solutions with polypeptides |
| FI98538C (fi) * | 1993-10-20 | 1997-07-10 | Enso Gutzeit Oy | Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä |
| US6306836B1 (en) | 1994-01-21 | 2001-10-23 | Baxter International Inc. | Peritoneal dialysis solutions containing maltodextrins and amino acids |
| US6436969B1 (en) | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| ES2322689T3 (es) * | 1999-09-22 | 2009-06-25 | Advanced Renal Technologies | Uso de un dializado con elevado contenido de citrato. |
| US7022315B2 (en) * | 2000-04-26 | 2006-04-04 | Oregon Health & Science University | Administration of a thiol-based chemoprotectant compound |
| JP4882054B2 (ja) * | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| JP5564158B2 (ja) | 2003-07-09 | 2014-07-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 亜硝酸塩によって特定の心臓血管状態を処置する方法 |
| WO2006001345A1 (ja) | 2004-06-23 | 2006-01-05 | Kyowa Hakko Kogyo Co., Ltd. | Ｌ－リジン・クエン酸塩結晶 |
| US20070154570A1 (en) | 2004-09-29 | 2007-07-05 | Miller Christopher C | Use of nitric oxide in the treatment and disinfection of biofilms |
| US7834065B2 (en) | 2005-01-31 | 2010-11-16 | Bmg Incorporated | Medical-use two part reactive adhesive and medical-use resin having self-degradation property |
| US20090304600A1 (en) | 2008-06-09 | 2009-12-10 | Anupkumar Shetty | Intradialytic administration of sodium thiosulfate |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| AU2010270605B2 (en) | 2009-07-08 | 2014-07-31 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| CA2844759A1 (en) | 2011-08-11 | 2013-02-14 | Nathan S. Bryan | Method of measuring and monitoring in vivo nitrite levels |
| WO2013112582A1 (en) | 2012-01-23 | 2013-08-01 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to clostridium infections |
| US9629872B2 (en) * | 2012-05-10 | 2017-04-25 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Sodium thiosulphate for the treatment of ectopic calcifications |
| JP5486069B1 (ja) * | 2012-11-05 | 2014-05-07 | 旭 酒井 | 透析装置 |
| US20140350097A1 (en) | 2013-05-23 | 2014-11-27 | Medinox,Inc. | Treatment of hypotension associated with hemodialysis |
| WO2016094409A1 (en) * | 2014-12-09 | 2016-06-16 | Villarreal Anna | Methods and devices for female health monitoring |
| IL268883B (en) * | 2017-03-08 | 2022-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| BR112019018861A2 (pt) | 2017-03-08 | 2023-10-10 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa |
-
2018
- 2018-03-06 IL IL268883A patent/IL268883B/en unknown
- 2018-03-06 WO PCT/US2018/021069 patent/WO2018165108A1/en not_active Ceased
- 2018-03-06 ES ES18764116T patent/ES2992792T3/es active Active
- 2018-03-06 EP EP24181083.7A patent/EP4403215A3/en active Pending
- 2018-03-06 KR KR1020247041494A patent/KR20250007674A/ko active Pending
- 2018-03-06 NZ NZ788158A patent/NZ788158A/en unknown
- 2018-03-06 NZ NZ756704A patent/NZ756704A/en unknown
- 2018-03-06 KR KR1020247030238A patent/KR102758644B1/ko active Active
- 2018-03-06 KR KR1020197029238A patent/KR102647836B1/ko active Active
- 2018-03-06 KR KR1020247008181A patent/KR102706439B1/ko active Active
- 2018-03-06 IL IL302827A patent/IL302827B2/en unknown
- 2018-03-06 IL IL312724A patent/IL312724A/en unknown
- 2018-03-06 IL IL295119A patent/IL295119B2/en unknown
- 2018-03-06 NZ NZ797802A patent/NZ797802A/en unknown
- 2018-03-06 JP JP2019548683A patent/JP7416622B2/ja active Active
- 2018-03-06 CA CA3055107A patent/CA3055107A1/en active Pending
- 2018-03-06 EP EP18764116.2A patent/EP3592824B1/en active Active
- 2018-03-06 NZ NZ797803A patent/NZ797803A/en unknown
- 2018-03-06 AU AU2018231072A patent/AU2018231072B2/en active Active
- 2018-03-07 US US15/914,661 patent/US10744156B2/en active Active
- 2018-03-07 AR ARP180100530A patent/AR111236A1/es not_active Application Discontinuation
- 2018-03-07 TW TW111149188A patent/TWI869743B/zh active
- 2018-03-07 TW TW107107748A patent/TWI789378B/zh active
-
2019
- 2019-08-28 PH PH12019501971A patent/PH12019501971A1/en unknown
-
2020
- 2020-07-13 US US16/927,901 patent/US11116790B2/en active Active
-
2021
- 2021-08-09 US US17/397,353 patent/US11779596B2/en active Active
- 2021-08-13 ZA ZA2021/05781A patent/ZA202105781B/en unknown
-
2022
- 2022-08-15 ZA ZA2022/09104A patent/ZA202209104B/en unknown
-
2023
- 2023-08-29 US US18/239,405 patent/US12370212B2/en active Active
-
2024
- 2024-01-04 JP JP2024000105A patent/JP7642878B2/ja active Active
-
2025
- 2025-02-26 JP JP2025028476A patent/JP2025084833A/ja active Pending
- 2025-07-02 US US19/258,074 patent/US20250332194A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202209104B (en) | Intradialytic use of sodium thiosulfate | |
| ZA202307367B (en) | Intradialytic use of sodium nitrite | |
| MX2021002321A (es) | Nuevos metodos. | |
| MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| MX2022011334A (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert. | |
| EP4570314A3 (en) | Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure | |
| PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX2019000677A (es) | Células miméticas de células b. | |
| MX2020005572A (es) | Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino. | |
| TN2016000498A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine. | |
| MX2017015664A (es) | Administracion intravenosa de citrulina durante cirugia. | |
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| PH12016501101A1 (en) | Veliparib in combination with carboplatin for the treatment of triple negative breast cancer | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции | |
| NZ763573A (en) | Dosage regimen of paliperidone palmitate extended-release injectable suspension | |
| MX2020006451A (es) | Tratamiento de la fibrosis con inositol. | |
| UA83680U (ru) | Способ комплексной реабилитации больных нейродермитом | |
| UA103987C2 (ru) | Способ терновской т.а. лечения варикозной болезни детей | |
| IN2014DE00822A (https=) |